Solid Biosciences

$3.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-2.22%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SLDB and other stocks, options, and ETFs commission-free!

About SLDB

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA. The listed name for SLDB is Solid Biosciences Inc. Common Stock.

CEO
Ilan Ganot
Employees
121
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
186.18M
Price-Earnings Ratio
Dividend Yield
Average Volume
520.45K
High Today
$3.25
Low Today
$3.07
Open Price
$3.15
Volume
282.55K
52 Week High
$6.10
52 Week Low
$1.93

Collections

SLDB Earnings

-$0.85
-$0.57
-$0.28
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like